Role of diet and fuel overabundance in the development and progression of heart failure
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Under physiological conditions, the human heart derives energy from glucose, fatty acids, and/or lactate depending upon substrate availability, circulating hormone levels, and nutritional status. Circulating free fatty acid and glucose levels often exceed the normal range, as observed with type 2 diabetes, obesity, or physical inactivity. Chronic exposure of the heart to high plasma levels of free fatty acids may cause accumulation of toxic lipid intermediates within cardiomyocytes. Furthermore, suppression of glucose oxidation by increased fatty acid uptake shunts glucose into the oxidative pentose phosphate and hexosamine biosynthetic pathways, both of which yield potentially harmful products. Noxious derivatives of aberrant glucose and fatty acid oxidation can activate signalling cascades leading to myocyte dysfunction or death, processes termed 'glucotoxicity' and 'lipotoxicity'. This review discusses the effects of dietary extremes (e.g. high fat and high carbohydrate consumption) and substrate overabundance in the context of heart failure (HF) development and progression. Emerging data suggest that substrate excess leads to cardiac dysfunction and HF, which may be prevented or slowed by maintaining low body fat and high insulin sensitivity and consuming a diet of low glycaemic load that is high in mono- and polyunsaturated fatty acids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093 · cited 1×
“An important effect of elevated plasma FFA on the heart is suppression of glucose and lactate uptake and oxidation through inhibition of phosphofructokinase and pyruvate dehydrogenase activity.(50,51) Reducing plasma FFA with diet or drugs rapidly decreases myocardial fatty acid oxidation and increases pyruvate oxidat…”
BackgroundLichtenstein, A. H., Appel, L. J., Brands, M., Carnethon, M., Daniels, S., Franch, H. A., Franklin, B., Kris-Etherton, P., Harris, W. S., Howard, B., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.176158 · Cited by 2,705
Optimal Diets for Prevention of Coronary Heart Disease
Hu, F. B. (2002) · JAMA · doi:10.1001/jama.288.20.2569 · Cited by 1,503 · cited 7×
“Regarding fat intake, numerous epidemiological studies have shown that diets low in saturated fat, trans fat, and cholesterol significantly lower risk for CHD. years of follow-up did not affect the rate of CHD events or stroke compared to no intervention.”
BackgroundInfluentialLipotoxic heart disease in obese rats: Implications for human obesity
Zhou, Y.-T., Grayburn, P., Karim, A., Shimabukuro, M., Higa, M., Baetens, D., Orci, L., & Unger, R. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1784 · Cited by 1,265
Liu, S., Willett, W. C., Stampfer, M. J., Hu, F. B., Franz, M., Sampson, L., Hennekens, C. H., & Manson, J. E. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.6.1455 · Cited by 1,166
Glucolipotoxicity: fuel excess and β-cell dysfunction
Poitout, V., & Robertson, R. P. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0023 · Cited by 1,092
Howard, B. V., Van Horn, L., Hsia, J., Manson, J. E., Stefanick, M. L., Wassertheil-Smoller, S., Kuller, L. H., LaCroix, A. Z., Langer, R. D., Lasser, N. L., et al. (2006) · JAMA · doi:10.1001/jama.295.6.655 · Cited by 1,091
Unger, R. H. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104057 · Cited by 875
Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart
Sharma, S., Adrogue, J. V., Golfman, L., Uray, I., Lemm, J., Youker, K., Noon, G. P., Frazier, O. H., & Taegtmeyer, H. (2004) · The FASEB Journal · doi:10.1096/fj.04-2263com · Cited by 790 · cited 2×
“Furthermore, cardiac biopsies from HF patients with obesity or type 2 diabetes have elevated myocardial TGs compared with healthy controls.(60) To date, no evidence provides a causal link between myocardial lipid accumulation and cardiac dysfunction or HF in a clinical population.”
BackgroundWhole-grain consumption and risk of coronary heart disease: results from the Nurses' Health Study
Liu, S., Stampfer, M. J., Hu, F. B., Giovannucci, E., Rimm, E., Manson, J. E., Hennekens, C. H., & Willett, W. C. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/70.3.412 · Cited by 774 · cited 6×
“Regarding fat intake, numerous epidemiological studies have shown that diets low in saturated fat, trans fat, and cholesterol significantly lower risk for CHD. years of follow-up did not affect the rate of CHD events or stroke compared to no intervention.”
BackgroundInfluentialPoitout, V., & Robertson, R. P. (2002) · Endocrinology · doi:10.1210/endo.143.2.8623 · Cited by 743
Cardiac Steatosis in Diabetes Mellitus: A 1 H-Magnetic Resonance Spectroscopy Study
McGavock, J. M., Lingvay, I., Zib, I., Tillery, T., Salas, N., Unger, R., Levine, B. D., Raskin, P., Victor, R. G., & Szczepaniak, L. S. (2007) · Circulation · doi:10.1161/circulationaha.106.645614 · Cited by 612 · cited 1×
“Recently, attention has been placed on lipid accumulation in the heart and the adverse effects on cardiac function and clinical outcome, particularly in diabetic or obese patients.(59,60) Morbidly obese individuals frequently present with hypertension, left ventricular hypertrophy (LVH), and impaired contractility as…”
BackgroundLow-Carbohydrate-Diet Score and the Risk of Coronary Heart Disease in Women
Halton, T. L., Willett, W. C., Liu, S., Manson, J. E., Albert, C. M., Rexrode, K., & Hu, F. B. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055317 · Cited by 519 · cited 3×
“Figure drawn from data published in Halton et al. acute ischaemic event.”
BackgroundMethodFinck, B. N., Han, X., Courtois, M., Aimond, F., Nerbonne, J. M., Kovacs, A., Gross, R. W., & Kelly, D. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0336724100 · Cited by 501
Miyazaki, Y., Mahankali, A., Matsuda, M., Glass, L., Mahankali, S., Ferrannini, E., Cusi, K., Mandarino, L. J., & DeFronzo, R. A. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.710 · Cited by 407
Barouch, L. A., Berkowitz, D. E., Harrison, R. W., O’Donnell, C. P., & Hare, J. M. (2003) · Circulation · doi:10.1161/01.cir.0000083716.82622.fd · Cited by 341 · cited 1×
“A similar phenotype is observed in obese leptin deficient ob/ob mice.(89,90) Due to the obesity, hyperinsulinaemia, and diabetes that develops in leptin-deficient animal models, it is difficult to ascertain Diet and fuel overabundance in heart failure 271”
BackgroundAlpert, M. A., Lambert, C. R., Panayiotou, H., Terry, B. E., Cohen, M. V., Massey, C. V., Hashimi, M. W., & Mukerji, V. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80338-5 · Cited by 292
Alpert, M. A., & Hashimi, M. W. (1993) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199308000-00011 · Cited by 245
Barouch, L. A., Gao, D., Chen, L., Miller, K. L., Xu, W., Phan, A. C., Kittleson, M. M., Minhas, K. M., Berkowitz, D. E., Wei, C., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000199348.10580.1d · Cited by 180
Beulens, J. W. J., de Bruijne, L. M., Stolk, R. P., Peeters, P. H. M., Bots, M. L., Grobbee, D. E., & van der Schouw, Y. T. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.068 · Cited by 163
Okere, I. C., Chandler, M. P., McElfresh, T. A., Rennison, J. H., Sharov, V., Sabbah, H. N., Tserng, K.-Y., Hoit, B. D., Ernsberger, P., Young, M. E., et al. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01295.2005 · Cited by 147 · cited 1×
“Normotensive rats fed a high fat diet (60% total energy from fat) for 8 weeks did not develop LVH compared with a high carbohydrate/low fat diet.(103) Inhibition of CPT-I increased cardiac TG content but did not lead to systolic dysfunction.”
BackgroundSelf-citationMortality in a Cohort of Men Expressing the Glucose-6-Phosphate Dehydrogenase Deficiency
Cocco, P., Todde, P., Fornera, S., Bonaria Manca, M., Manca, P., & Rosa Sias, A. (1998) · Blood · doi:10.1182/blood.v91.2.706 · Cited by 112
Okere, I. C., Young, M. E., McElfresh, T. A., Chess, D. J., Sharov, V. G., Sabbah, H. N., Hoit, B. D., Ernsberger, P., Chandler, M. P., & Stanley, W. C. (2006) · Hypertension · doi:10.1161/01.hyp.0000248430.26229.0f · Cited by 104 · cited 1×
“Feeding a high fat diet to hypertensive Dahl salt-sensitive rats attenuated LVH, contractile dysfunction, and LV dilation compared with a high carbohydrate chow.(105,106) Hypertension in the Dahl rat is induced by high dietary salt intake(107) which, subsequently, may alter feeding behaviour and macronutrient intake.”
BackgroundSelf-citationThe case for low carbohydrate diets in diabetes management
Arora, S. K., & McFarlane, S. I. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-16 · Cited by 102 · cited 1×
“Low carbohydrate/high fat diets have also been shown to improve biomarkers of cardiovascular disease in normal weight, normolipidemic subjects independent of weight loss.(35) Based on these and other findings, nutritional guidelines have shifted away from the old diet-CHD paradigm that paid little attention to carbohy…”
BackgroundGlycemic index and heart disease,,
Leeds, A. R. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.1.286s · Cited by 99
Morgan, E. E., Rennison, J. H., Young, M. E., McElfresh, T. A., Kung, T. A., Tserng, K.-Y., Hoit, B. D., Stanley, W. C., & Chandler, M. P. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01014.2005 · Cited by 86 · cited 1×
“A high fat diet had no adverse effects on LV remodelling or systolic function compared with a high carbohydrate/low fat diet despite increases in plasma FFAs, TGs, and leptin in animals subjected to coronary artery ligation.(84,111) Myocardial TG and ceramide content were both increased but were not associated with wo…”
BackgroundSelf-citationKong, J. Y., & Rabkin, S. W. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00257.2001 · Cited by 61
Cited by
Myocardial Fatty Acid Metabolism in Health and Disease
Lopaschuk, G. D., Ussher, J. R., Folmes, C. D. L., Jaswal, J. S., & Stanley, W. C. (2010) · Physiological Reviews · doi:10.1152/physrev.00015.2009 · Cited by 2,179
Self-citationCardiovascular consequences of metabolic syndrome
Tune, J. D., Goodwill, A. G., Sassoon, D. J., & Mather, K. J. (2017) · Translational Research · doi:10.1016/j.trsl.2017.01.001 · Cited by 568
Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents
Di Pino, A., & DeFronzo, R. A. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00141 · Cited by 535
Return to the fetal gene program: A suggested metabolic link to gene expression in the heart
Taegtmeyer, H., Sen, S., & Vela, D. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05100.x · Cited by 411
Wende, A. R., & Abel, E. D. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.023 · Cited by 343
Metadata
- Authors
- Chess, D. J., & Stanley, W. C.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-04-30
- Volume
- 79
- Issue
- 2
- Pages
- 269-278
- ISSN
- 0008-6363 (ISSN-L)
- OpenAlex
- W2122954934
- Cited by
- 140
- References
- 27
- FWCI
- 8.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.